Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. symbols : Bhvn save search
Pfizer Reports First-Quarter 2023 Results
Published: 2023-05-02 (Crawled : 12:20) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -0.52%
H: 0.44%
C: -2.29%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -0.84%
H: 2.03%
C: 0.01%
results
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -1.26%
H: 2.97%
C: 2.7%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -0.48%
H: 4.49%
C: 3.24%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -1.74%
H: 4.84%
C: 3.88%
BEAM | $23.46 -2.66% -2.73% 1.2M
|
Health Technology
|
| O: 0.21%
H: 4.84%
C: 2.99%
financial results
Global Spinal Muscular Atrophy Treatment Market Report 2022: Sector to Reach $11.4 Billion by 2028 at a 17.8% CAGR
Published: 2023-01-09 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 3.12%
H: 0.0%
C: -2.55%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -1.71%
H: 0.42%
C: -3.32%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.76%
H: 0.26%
C: -3.27%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: 0.35%
H: 9.67%
C: 3.25%
SRRK 4 | $14.79 5.64% 5.34% 740K
|
Health Technology
|
| O: 1.5%
H: 2.42%
C: -0.11%
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
|
| O: 0.1%
H: 10.44%
C: 5.66%
IONS | $41.85 1.9% 1.86% 630K
|
Health Technology
|
| O: -0.17%
H: 0.84%
C: -7.91%
treatment global report market muscular atrophy
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.41 0.6% 0.0% 3.1M
|
n/a
|
| O: 0.16%
H: 1.79%
C: 0.16%
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: -0.27%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 3.11%
H: 0.88%
C: 0.02%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 1.72%
H: 0.39%
C: -0.83%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: 1.81%
H: 3.08%
C: -0.65%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
BEAM | $23.46 -2.66% -2.73% 1.2M
|
Health Technology
|
| O: 3.25%
H: 1.41%
C: -2.48%
ARVN | $33.96 -2.69% -2.77% 530K
|
Health Technology
|
| O: 1.49%
H: 3.25%
C: 1.68%
results
Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments
Published: 2022-08-05 (Crawled : 11:00) - prnewswire.com
TSLX | $21.185 -0.68% -0.02% 340K
|
Finance
|
| O: -0.11%
H: 1.3%
C: 1.28%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.44%
H: 0.66%
C: -0.75%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -0.41%
H: 0.38%
C: 0.33%
results
Pfizer Reports Second-Quarter 2022 Results
Published: 2022-07-28 (Crawled : 11:00) - biospace.com/
HLN | $8.41 0.6% 0.0% 3.1M
|
n/a
|
| O: -1.64%
H: 0.56%
C: -2.78%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -2.13%
H: 2.92%
C: -0.25%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -0.14%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -4.75%
H: 0.36%
C: -3.74%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 1.35%
H: 4.51%
C: 4.39%
BEAM | $23.46 -2.66% -2.73% 1.2M
|
Health Technology
|
| O: -0.04%
H: 1.99%
C: -3.1%
results
BIOHAVEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Biohaven Pharmaceutical Holding Company Ltd. - BHVN
Published: 2022-05-11 (Crawled : 04:00) - prnewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.0%
H: 2.37%
C: 0.77%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -0.39%
H: 0.28%
C: -0.12%
Pfizer to Acquire Biohaven Pharmaceuticals
Published: 2022-05-10 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: 0.0%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: 60.35%
H: 0.0%
C: 0.0%
Pfizer Reports First-Quarter 2022 Results
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 1.77%
H: 2.39%
C: 0.86%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: 4.37%
H: 0.98%
C: -3.34%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
SGMO | News | $0.5212 2.18% 2.13% 2.3M
|
Health Technology
|
| O: 7.97%
H: 2.91%
C: 0.0%
OPK | $1.245 1.22% 1.2% 2.4M
|
Health Technology
|
| O: 2.94%
H: 4.64%
C: 3.21%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 3.06%
H: 3.6%
C: 2.08%
BEAM | $23.46 -2.66% -2.73% 1.2M
|
Health Technology
|
| O: 8.78%
H: 3.69%
C: -2.08%
results
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
Published: 2022-04-27 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.37%
H: 1.63%
C: 1.28%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -4.64%
H: 3.6%
C: 0.93%
vydura treatment granted migraine authorization
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Published: 2022-02-25 (Crawled : 13:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -4.17%
H: 0.0%
C: 0.0%
treatment migraine positive chmp
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -1.89%
H: 1.36%
C: -0.04%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: 0.27%
H: 2.86%
C: 1.95%
treatment trial migraine china topline results positive results topline
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
Published: 2022-02-08 (Crawled : 12:00) - biospace.com/
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: 0.07%
H: 0.44%
C: -0.2%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -4.81%
H: 2.29%
C: 2.09%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -2.75%
H: 3.07%
C: 2.01%
SGMO | News | $0.5212 2.18% 2.13% 2.3M
|
Health Technology
|
| O: 0.35%
H: 1.32%
C: -0.88%
OPK | $1.245 1.22% 1.2% 2.4M
|
Health Technology
|
| O: 0.31%
H: 0.31%
C: -2.15%
IONS | $41.85 1.9% 1.86% 630K
|
Health Technology
|
| O: 2.98%
H: 3.02%
C: 1.52%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -7.54%
H: 2.13%
C: -1.69%
BEAM | $23.46 -2.66% -2.73% 1.2M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
report results
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
Published: 2022-01-05 (Crawled : 17:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: 0.43%
H: 0.9%
C: -4.35%
commercialization collaboration
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Published: 2021-11-09 (Crawled : 13:00) - prnewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -20.3%
H: 0.0%
C: 0.0%
commercialization collaboration
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.